Series C - Innate Pharma - Sep 1, 2004 Funding Round Profile - Cointime

Bitcoin $86,561.43 -3.50%
Ethereum $3,132.34 -7.66%
BNB $604.65 -7.20%
Optimism $1.52 -16.43%
Arbitrum $0.58 -15.24%
Solana $203.35 -7.87%
Polygon $0.36 -14.39%
Cosmos $4.89 -12.91%
Avalanche $31.68 -14.39%

Bitcoin $86,561.43 -3.50%
Ethereum $3,132.34 -7.66%
BNB $604.65 -7.20%
Optimism $1.52 -16.43%
Arbitrum $0.58 -15.24%
Solana $203.35 -7.87%
Polygon $0.36 -14.39%
Cosmos $4.89 -12.91%
Avalanche $31.68 -14.39%

Innate Pharma

company

Funding Round

Series C

Money Raised

€ 15M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Novo Nordisk	-	-	-	Detail
Akka Venture	-	-	-	Detail
NIF SMBC Ventures	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Jan 1, 2002	Series B	€ 20M	Akka Venture	Detail